AbiomedCompany Review & Valuation

ABMD
Nasdaq
Latest Price
251.88USD
Market Capitalization
11.38bUSD

About Abiomed, Inc.

ABIOMED, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides continuum of care to heart failure patients. The company offers Impella 2.5 catheter, a percutaneous micro heart pump with integrated motorShow more and sensors for use in interventional cardiology; and Impella CP, a device used by interventional cardiologists to support patients in the cath lab and cardiac surgeons in the heart surgery suite. It also provides Impella 5.0 and Impella LD, which are percutaneous micro heart pumps with integrated motors and sensors for use primarily in the heart surgery suite; and Impella RP, a percutaneous catheter-based axial flow pump. In addition, the company is involved in the development of Impella 5.5 and Impella BTR that are percutaneous micro heart pumps with integrated motors and sensors; and Impella ECP pump, a device for blood flow of greater than three liters per minute. It sells its products through direct sales and clinical support personnel in the United States, Canada, Europe, and Japan. The company was founded in 1981 and is headquartered in Danvers, Massachusetts.Show less

Industry
Medical Devices
HQ Location
Danvers, Massachusetts
Wikipedia

Stock Price

Price data not available for Abiomed.

Performance

Please login or create a free account to view the contents of this section.

Similar Companies

Zimmer Biomet Holdings
AirXpanders
aap Implantate
Neovasc

back to top